Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuvan long-term neurocognitive outcomes in children with PKU
NCT01965912Phase 4Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Oct 2013
- Primary completion
- Jan 2023
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
A Phase 4 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Oct 2013; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01965912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01965912.